HOXC10 dysregulation has been demonstrated to be closely associated with ESCC development, and HOXC10 overexpression drives ESCC cell growth and enhances the resistance to chemoradiotherapy in ESCC [20]. The gene discussed is HOXC10; the disease is esophageal squamous cell carcinoma.